New immune pathways from chronic post‐viral lung disease
- 12 January 2010
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1183 (1), 195-210
- https://doi.org/10.1111/j.1749-6632.2009.05136.x
Abstract
To better understand the immunopathogenesis of chronic inflammatory lung disease, we established a mouse model of disease that develops after respiratory viral infection. The disease that develops in this model is similar to chronic obstructive lung disease in humans. Using this model we have characterized two distinct phases in the chronic disease process. The first phase appears at three weeks after viral infection and depends on type I interferon‐dependent expression and then subsequent activation of the high‐affinity IgE receptor (FcɛRI) on conventional lung dendritic cells, which in turn recruit IL‐13‐producing CD4+ T cells to the lower airways. The second phase becomes maximal at seven weeks after infection and depends on invariant natural killer T (iNKT) cells and lung macrophages. Cellular cross‐talk relies on interactions between the semi‐invariant Vα14Jα18 T‐cell receptor on lung iNKT cells and CD1d on macrophages as well as iNKT cell‐derived IL‐13 and IL‐13 receptor on macrophages. These interactions drive macrophages to a pattern of alternative activation and overproduction of IL‐13. This innate immune axis is also activated in patients with chronic obstructive lung disease, as evidenced by increased numbers of iNKT cells and IL‐13‐producing alternatively activated macrophages marked by chitinase 1 production. Together the findings identify two new immune pathways responsible for early and late phases of chronic inflammatory lung disease in experimental and clinical settings. These findings extend our understanding of the complex mechanisms that underlie chronic obstructive lung disease and provide useful targets for diagnosis and therapy of this common disorder.This publication has 102 references indexed in Scilit:
- Respiratory Syncytial Virus Persistence in the Lungs Correlates with Airway Hyperreactivity in the Mouse ModelThe Journal of Infectious Diseases, 2008
- 12/15-Lipoxygenase deficiency protects mice from allergic airways inflammation and increases secretory IgA levelsJournal of Allergy and Clinical Immunology, 2008
- Persistent activation of an innate immune response translates respiratory viral infection into chronic lung diseaseNature Medicine, 2008
- IL13 gene polymorphisms modify the effect of exposure to tobacco smoke on persistent wheeze and asthma in childhood, a longitudinal studyRespiratory Research, 2008
- Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasiaThe Journal of Experimental Medicine, 2007
- Survival after Lung Volume Reduction in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- High-Throughput, Sensitive, and Accurate Multiplex PCR-Microsphere Flow Cytometry System for Large-Scale Comprehensive Detection of Respiratory VirusesJournal of Clinical Microbiology, 2007
- Interleukin-17 is a negative regulator of established allergic asthmaThe Journal of Experimental Medicine, 2006
- An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and EmphysemaPLoS Medicine, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003